A virtual Experts Knowledge Share on the topic of ‘The evolving TROP2-directed antibody drug conjugates (ADC) landscape in metastatic non-small cell lung cancer (mNSCLC) and strategies to optimise the treatment experience’  with Scientific Committee Prof. Nicolas Girard (France), Dr Louise Lim (UK), Dr Jacob Sands (US) and Mrs Stephanie McDonald (US).

Topics of conversation include: 

• The relevance of TROP2 in mNSCLC
• Clinical overview of TROP2-directed ADCs in NSCLC:

  • Pre-treated advanced/mNSCLC
  • Ongoing 1st line advanced/mNSCLC
• Optimising the treatment experience: proactive AE monitoring & management 
• Best practice management: panel discussion and audience questions 

This event is in collaboration with LUNG CANCER CONNECT, an international group of experts in the field of thoracic oncology and is an initiative of COR2ED.  

Don’t miss the opportunity to contribute to the discussion on this important topic.  

Please submit your patient case study/questions for the faculty to selina.gill@cor2ed.com by 4^th May.